Spots Global Cancer Trial Database for chemotherapy
Every month we try and update this database with for chemotherapy cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
A Study of Gimatecan (ST1481) in Small Cell Lung Cancer | NCT04501029 | Small Cell Lung... | Gimatecan | 18 Years - 75 Years | Lee's Pharmaceutical Limited | |
Bristol Bladder Trial | NCT01616875 | Infiltrating Bl... | Cabazitaxel + C... | 18 Years - | University Hospitals Bristol and Weston NHS Foundation Trust | |
Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian or Primary Peritoneal Cancer | NCT00005046 | Ovarian Cancer Primary Periton... | chemotherapy paclitaxel | 21 Years - | GOG Foundation | |
Safety Study of Combining Ultrasound Microbubbles and Chemotherapy to Treat Malignant Neoplasms of Digestive System | NCT02233205 | Gastrointestina... | ultrasonic micr... platinum and ge... | 18 Years - 75 Years | Peking University Cancer Hospital & Institute | |
Second-line Therapy Versus Supportive Care for Pretreated Advanced Gastric Cancer | NCT00821990 | Advanced Gastri... | Chemotherapy Best supportive... | - 75 Years | Samsung Medical Center | |
SMD_FLAG-IDA_98: FLAG-IDA in Induction Treatment of High Risk Myelodysplastic Syndromes or Secondary Acute Myeloblastic Leukemia | NCT00487448 | Myelodysplastic... Acute Myeloblas... | Fludarabine Cytarabine G-CSF Idarubicin Peripheral bloo... Bone marrow tra... | - 75 Years | PETHEMA Foundation | |
Vaccination in the Peripheral Stem Cell Transplant Setting for Multiple Myeloma | NCT00116441 | Multiple Myelom... | Therapeutic Cel... | 18 Years - 70 Years | Cell Genesys | |
A Study of Endostar Combined With Chemotherapy for Treatment of Osteosarcoma | NCT01002092 | Osteosarcoma | Chemotherapy Endostar | 12 Years - 60 Years | Shandong Simcere-Medgenn Bio-pharmaceutical Co., Ltd | |
Combination Chemotherapy in Treating Older Patients With Solid Tumour, | NCT00664911 | Solid Tumor Reg... | chemotherapy | 75 Years - | GERCOR - Multidisciplinary Oncology Cooperative Group | |
Thiopurine Methyltransferase Polymorphisms Evaluation | NCT00166647 | Cancer | Blood Sampling | - 18 Years | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | |
Cardiac Dysfunction in Childhood Cancer Survivors | NCT03790943 | Cardiac Dysfunc... Cardiovascular ... Childhood Cance... | cardiac assessm... | 18 Years - | University of Bern | |
Once Weekly Radiation for Lung Cancer With Chemotherapy | NCT00256789 | Carcinoma, Non-... | Radiation Chemotherapy | - | Clinical Oncology Research Associates | |
Pilot Study of Expanded, Donor Natural Killer Cell Infusions for Refractory Non-B Lineage Hematologic Malignancies and Solid Tumors | NCT00640796 | Leukemia, Myelo... Leukemia, Lymph... Juvenile Myelom... T-cell Lymphobl... Myelodysplastic... | Haploidentical ... Chemotherapy CliniMACS | - 18 Years | St. Jude Children's Research Hospital | |
Efficacy and Safety Study of PDT Using Photofrin in Unresectable Advanced Perihilar Cholangiocarcinoma (OPUS) | NCT02082522 | Hilar Cholangio... | Photodynamic th... Stenting proced... Chemotherapy re... | 18 Years - | Concordia Laboratories Inc. | |
Treatment of Disseminated High Grade Lymphoma | NCT00536393 | Lymphoma | Doxorubicin Doxorubicin peg... | 60 Years - 75 Years | French Innovative Leukemia Organisation | |
Power Injectable Versus a Non-Power Injectable, Upper Arm, TIVAD for Chemotherapy | NCT02282449 | Malignancy | Power Injectabl... Non-Power Injec... | 16 Years - | University of Saskatchewan | |
Hypofractionated Accelerated Radiotherapy With Concomitant Chemotherapy for NSCLC | NCT02367443 | Non-small Cell ... | Radiation | 18 Years - 75 Years | Independent Public Care Health Facility of the Ministry of the Interior and Warmian & Mazurian Oncology Centre | |
Clinical Study of Epoetin Beta to Chemotherapy-Induced Anemia (CIA) Patients | NCT00628043 | Anemia | epoetin beta placebo | 20 Years - 79 Years | Chugai Pharmaceutical | |
Study Comparing Tumor Debulking Surgery Versus Chemotherapy Alone in Recurrent Platinum-Sensitive Ovarian Cancer | NCT01166737 | Fallopian Tube ... Ovarian Cancer Peritoneal Cavi... | Tumor Debulking... | 18 Years - | AGO Study Group | |
Combination of Paclitaxel-bevacizumab ± Atezolizumab in Patients With Advanced NSCLC Progressing After Immunotherapy & Chemotherapy | NCT05781308 | Non Small Cell ... | Paclitaxel Bevacizumab Atezolizumab | 18 Years - | Intergroupe Francophone de Cancerologie Thoracique | |
MFOLFIRINOX And Stereotactic Radiotherapy (SBRT) for Pancreatic Cancer With High Risk and Locally Advanced Disease | NCT04089150 | Pancreatic Canc... | Stereotactic Ra... mFOLFIRINOX Gemcitabine + N... Gemcitabine + C... Pancreatoduoden... | 18 Years - 75 Years | Australasian Gastro-Intestinal Trials Group | |
Total Neoadjuvant Therapy of SCRT+CAPOX vs SCRT+CAPOXIRI for Locally Advanced Rectal Cancer (ENSEMBLE) | NCT05646511 | Locally Advance... | SCRT CAPOX CAPOXIRI | 18 Years - | National Cancer Center Hospital East | |
Ramosetron, Aprepitant and Dexamethasone (RAD) in Solid Cancer | NCT01046461 | Solid Tumour Postoperative N... | Ramosetron, Apr... | 18 Years - 75 Years | Hallym University Medical Center | |
The Effect of Resistance Training and Aerobic Training on Body Composition During Chemotherapy | NCT02192216 | Neoplasms | Exercise | 18 Years - | Department of Public Health, Denmark | |
Postoperative Chemoradiation or Chemotherapy After Preoperative Chemotherapy for Gastric Cancers | NCT03515941 | Gastrointestina... | Oxaliplatin Capecitabine Leucovorin 5-fluorouracil radiation | 18 Years - | Baylor College of Medicine | |
Methotrexate With or Without Antineoplaston Therapy in Treating Postmenopausal Women With Advanced Refractory Breast Cancer | NCT00003536 | Stage IV Breast... Recurrent Breas... | antineoplaston ... methotrexate alternative pro... biological ther... biologically ba... cancer preventi... chemotherapy complementary a... differentiation... | - | National Cancer Institute (NCI) | |
Investigational Agent AG-013736 In Combinations With Standard Of Care Treatments For Patient's With Advanced Solid Tumor | NCT00454649 | Neoplasms | Axitinib + Pacl... Axitinib + Pacl... Axitinib + Pacl... Axitinib + Pacl... Axitinib + Doce... Axitinib + Doce... Axitinib + Cape... Axitinib + Cape... Axitinib + Gemc... Axitinib + Peme... | 18 Years - | Pfizer | |
A Phase 1/2 Study of PXD101 (Belinostat) in Combination With Cisplatin, Doxorubicin and Cyclophosphamide in the First Line Treatment of Advanced or Recurrent Thymic, Malignancies | NCT01100944 | Thymoma Thymic Carcinom... | PXD101with cisp... | 18 Years - 100 Years | National Institutes of Health Clinical Center (CC) | |
Molecular Analysis and Treatment Options of SCLC | NCT05945745 | Small-cell Lung... Small Cell Lung... Small Cell Lung... Small Cell Lung... Small Cell Lung... | Chemotherapy | 18 Years - | Shanghai Chest Hospital | |
Avastin Plus Chemotherapy vs. Avastin Plus Chemotherapy Guided by Cancer Stem Cell Test in Recurrent Ovarian Cancer | NCT03632798 | Recurrent Ovari... | ChemoID assay Chemotherapy | 18 Years - | Cordgenics, LLC | |
Study of Prognostic Biomarkers of Survival at 6 Months for Patients Treated With Bevacizumab Glioblastomas in First Relapse After Failure of Radiochemotherapy | NCT03144167 | Glioblastoma Radiotherapy Chemotherapy | Analysis of spe... | 18 Years - | Centre Hospitalier Universitaire, Amiens | |
A Multicenter Single-arm P2 to Evaluate Safety and Efficacy of the Total Neoadjuvant Therapy for cT2 Rectal Cancer | NCT05939661 | Rectal Cancer | Radiation Chemotherapy Surgery | 18 Years - | Osaka University | |
Nurse-led Care Program for Cancer Patients in Chemotherapy Day Center | NCT02228200 | Breast Neoplasm... Colorectal Neop... | Nurse-led care Routine care | 18 Years - | The Hong Kong Polytechnic University | |
Efficacy of Chemotherapy Combined With Regional Hypothermia in Advanced Malignant Melanoma Patients With Progressive Soft Tissue Metastases | NCT00264056 | Advanced Metast... Refractory to F... | hyperthermia | 18 Years - 70 Years | Fachklinik Hornheide an der Universität Münster | |
Study of Pembrolizumab and Chemotherapy With or Without Radiation in Small Cell Lung Cancer (SCLC) | NCT02934503 | Small Cell Lung... | Pembrolizumab Cisplatin Carboplatin Etoposide Radiation thera... | 19 Years - | NYU Langone Health | |
Valproic Acid With Temozolomide and Radiation Therapy to Treat Brain Tumors | NCT00302159 | High Grade Glio... Brain Tumors | adjuvant therap... Temozolomide Valproic Acid Radiation thera... | 18 Years - 90 Years | National Institutes of Health Clinical Center (CC) | |
Microbiota Transplant in Advanced Lung Cancer Treated With Immunotherapy | NCT04924374 | Lung Cancer | Microbiota Tran... anti PD1 therap... | 18 Years - | Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal | |
Peppermint Inhalation Versus Swedish Massage on Chemotherapy Induced-Nausea and Vomiting in Children With Leukemia | NCT06095726 | Leukemia | Peppermint Inha... Swedish Massage | 6 Years - 15 Years | Alexandria University | |
Dynamic Contrast-enhanced MRI Combined With IVIM-DWI for Early Prediction of Chemosensitivity in Liver MBC | NCT05550090 | Metastatic Brea... | Chemotherapy | 18 Years - | Zhejiang Cancer Hospital | |
A Study in Adults With Untreated Acute Lymphoblastic Leukemia | NCT00136435 | Acute Lymphobla... | prednisone doxorubicin vincristine methotrexate asparaginase dexamethasone cranial radiati... leucovorin cytarabine hydrocortisone 6-mercaptopurin... e. coli L-aspar... | 18 Years - 50 Years | Dana-Farber Cancer Institute | |
Itraconazole in Advanced Ovarian Cancer | NCT05591560 | Ovarian Carcino... | Itraconazole ca... Placebo | 18 Years - 65 Years | Tanta University | |
Study of PD-1 Antibody and Bevacizumab in the Treatment of High-risk GTN After Combined Chemotherapy | NCT04812002 | Gestational Tro... | PD-1 inhibitor,... | 18 Years - 75 Years | Women's Hospital School Of Medicine Zhejiang University | |
ACVBP Plus Rituximab in Patients Aged From 18 to 59 Years With High-risk Diffuse Large B-cell Lymphoma | NCT00144807 | Diffuse Large C... | rituximab doxorubicin cyclophosphamid... autologous stem... | 18 Years - 59 Years | Lymphoma Study Association | |
Study BT8009-230 in Participants With Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2) | NCT06225596 | Metastatic Urot... | BT8009 BT8009 BT8009 Pembrolizumab Gemcitabine + c... Avelumab | 18 Years - | BicycleTx Limited | |
Neoadjuvant Chemotherapy, Tislelizumab With Afatinib for HNSCC | NCT05516589 | Head and Neck S... | Nab-paclitaxel Cisplatin Tislelizumab Afatinib | 18 Years - | West China Hospital | |
Optimizing and Personalising Azacitidine Combination Therapy for Treating Solid Tumours QPOP and CURATE.AI | NCT05381038 | Solid Tumor Gastrointestina... Breast Cancer | QPOP CURATE.AI Azacitidine + d... Azacitidine + p... Azacitidine + i... | 21 Years - 99 Years | National University Hospital, Singapore | |
Effect of All-trans Retinoic Acid With Chemotherapy Based in Paclitaxel and Cisplatin as First Line Treatment of Patients With Advanced Non-small Cell Lung Cancer | NCT01048645 | Non-Small-Cell ... | ATRA PLACEBO | 18 Years - 80 Years | National Institute of Cancerología | |
Apatinib and Etoposide in Patients With Platinum Resistant or Refractory Ovarian Cancer | NCT02867956 | Ovarian Cancer | Apatinib Etoposide | 18 Years - 70 Years | Sun Yat-sen University | |
Suramin in Treating Patients With Recurrent Primary Brain Tumors | NCT00002639 | Brain and Centr... | chemotherapy suramin | 15 Years - | National Cancer Institute (NCI) | |
Evaluation of Effects of Silymarin on Cisplatin Induced Nephrotoxicity in Upper Gastrointestinal Adenocarcinoma | NCT01829178 | Upper GI Cancer Cisplatin Adver... | Silymarin Placebo chemotherapy | 18 Years - 70 Years | Tehran University of Medical Sciences | |
2nd Line Erlotinib Treatment With (Out) Chemotherapy of Advanced Non Small Cell Lung Cancer (NSCLC) | NCT00835471 | Carcinoma, Non-... | erlotinib plus ... erlotinib | 18 Years - | Dutch Society of Physicians for Pulmonology and Tuberculosis | |
Carboxyamidotriazole and Ketoconazole in Treating Patients With Advanced Cancers | NCT00003249 | Unspecified Adu... | carboxyamidotri... chemotherapy ketoconazole | 18 Years - | National Cancer Institute (NCI) | |
Metformin and Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer | NCT02122185 | Brenner Tumor Malignant Ascit... Malignant Pleur... Ovarian Clear C... Ovarian Endomet... Ovarian Mixed E... Ovarian Serous ... Ovarian Undiffe... Recurrent Fallo... Recurrent Ovari... Recurrent Ovari... Recurrent Prima... Stage IIIA Fall... Stage IIIA Ovar... Stage IIIA Ovar... Stage IIIA Prim... Stage IIIB Fall... Stage IIIB Ovar... Stage IIIB Ovar... Stage IIIB Prim... Stage IIIC Fall... Stage IIIC Ovar... Stage IIIC Ovar... Stage IIIC Prim... Stage IV Fallop... Stage IV Ovaria... Stage IV Ovaria... Stage IV Primar... | metformin hydro... placebo Chemotherapy | 18 Years - | University of Chicago | |
Neoadjuvant and Adjuvant Chemotherapy in High-risk Soft Tissue Sarcoma | NCT01382030 | Soft Tissue Sar... | EIA chemotherap... | 18 Years - 65 Years | Heidelberg University | |
LEE011 Plus Everolimus in Patients With Metastatic Pancreatic Adenocarcinoma Refractory to Chemotherapy | NCT02985125 | Metastatic Panc... | LEE011 Everolimus | 18 Years - | Georgetown University | |
Caphosol Study: Prevention of Oral Mucositis in Children, Adolescents and Young Adults Receiving Chemotherapy | NCT02539342 | Oral Mucositis | Caphosol Biotene | - 25 Years | Medical College of Wisconsin | |
Picoplatin as Second-Line Therapy for Patients With Small Cell Lung Cancer | NCT00116610 | Small Cell Lung... | picoplatin | 18 Years - | Poniard Pharmaceuticals | |
Long Term Follow up of Patients Under 5 Years of Age With High Grade Glioma Diagnosed in France Between 1990 and 2015 | NCT03690570 | Glioma | 1 Day - 5 Years | University Hospital, Strasbourg, France | ||
The Synergism Or Long Duration (SOLD) Study | NCT00593697 | Breast Neoplasm... | trastuzumab (9 ... trastuzumab (9 ... | 18 Years - | Finnish Breast Cancer Group | |
A Feasibility Study to Evaluate Adjuvant Chemoradiotherapy for Gastric Cancer | NCT00123318 | Gastric Cancer | epirubicin cisplatin 5-fluorouracil Radiotherapy | 18 Years - | Trans Tasman Radiation Oncology Group | |
Thalidomide Prevention or Treatment of Camrelizumab-induced Reactive Cutaneous Capillary Endothelial Proliferation (RCCEP) | NCT06231680 | Lung Cancer, No... Esophageal Carc... | Camrelizumab Thalidomide 50m... Thalidomide 100... Thalidomide 200... Chemotherapy | 18 Years - | Henan Cancer Hospital | |
Phase I Study of Continuous Infusion Schedule of FMdC in Hematologic Malignancies | NCT00061620 | Hematologic Mal... | Tezacitabine (F... | 15 Years - | M.D. Anderson Cancer Center | |
MicroEnvironment Tumor Effects of Radiotherapy - Comprehensive Radiobiology Assessment TRial | NCT05975593 | Locally Advance... Locally Advance... Locally Advance... Locally Advance... Locally Advance... Cervical Cancer Pancreas Cancer Pancreatic Canc... Cancer of the C... Cancer of the P... | 18 Years - | Washington University School of Medicine | ||
Recognition of Circulating Tumor DNA in Soft Tissue Sarcoma | NCT03896620 | Sarcoma | Preoperative RT Postoperative R... Chemotherapy Surgery | 18 Years - | Medical College of Wisconsin | |
Impact of Physical Activity on Biomarker of Aging and Body Composition Among Breast Cancer Survivors Age 65 and Older | NCT02328313 | Breast Cancer Aging Physical Activi... | Walk with Ease ... | 65 Years - | UNC Lineberger Comprehensive Cancer Center | |
SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adult Cancer Patients Receiving Chemotherapy | NCT00102726 | Thrombocytopaen... | SB497115 Placebo | 18 Years - | GlaxoSmithKline | |
Effect of IMN1207 Versus Casein on Weight Loss, Survival and Quality of Life in Non-small Cell Lung Cancer Patients | NCT01046383 | NON-SMALL CELL ... | IMN1207 Casein | 18 Years - | Immunotec Inc. | |
Evaluation of Efficacy and Safety of FOLFIRI Association Treatment in Patients 70 Years of Age and Older With Gastric Cancer | NCT00210184 | Gastric Cancer | Irinotecan asso... | 70 Years - 100 Years | Institut Bergonié | |
Efficacy Study of Chemotherapy to Treat Ovarian Cancer Recurrence by Prolonging the Platinum Free Interval | NCT00657878 | Ovarian Cancer | stealth liposom... carboplatin paclitaxel Topotecan Gemcitabine | - | National Cancer Institute, Naples | |
A Study of Pembrolizumab Plus Epacadostat With Platinum-based Chemotherapy Versus Pembrolizumab Plus Platinum-based Chemotherapy Plus Placebo in Metastatic Non-Small Cell Lung Cancer (KEYNOTE-715-06/ECHO-306-06) | NCT03322566 | Lung Cancer | Pembrolizumab Epacadostat Platinum-based ... Placebo | 18 Years - | Incyte Corporation | |
Evaluation of Oral Morphine Gel in Oral Mucositis Induced by Chemotherapy in Children and Young Adults | NCT02173756 | Cancer | morphine gel placebo gel | 5 Years - 25 Years | University Hospital, Strasbourg, France | |
Physical Activity and Testicular Cancer | NCT01749774 | Testicular Canc... | Physical activi... | 18 Years - | Oslo University Hospital | |
Magrolimab in Combination With Cytotoxic Chemotherapy in Advanced Urothelial Carcinoma | NCT05738161 | Advanced Urothe... | Magrolimab Cisplatin Gemcitabine | 18 Years - | Insel Gruppe AG, University Hospital Bern | |
MONET1-MOtesanib NSCLC Efficacy and Tolerability Study | NCT00460317 | Non-Small Cell ... | AMG 706 placebo paclitaxel carboplatin | 18 Years - | Amgen | |
Weekly Dosing of an Integrative Chemotherapy Combination to Treat Advanced Pancreatic Cancer | NCT00323583 | Adenocarincoma ... Stage III Pancr... Stage IVA Pancr... Stage IVB Pancr... | paclitaxel oxaliplatin leucovorin 5-fluorouracil glutathione calcium and mag... Chemotherapy Chemoprotection Complementary a... | 18 Years - 65 Years | Seattle Cancer Treatment and Wellness Center | |
Vinorelbine-ifosfamide Versus Gefitinib for EGFR Gene Mutation Negative Non-small Cell Lung Cancer Patients | NCT01749072 | Non-small Cell ... Effects of Chem... | Gefitinib group Vinorelbine, If... | 18 Years - 70 Years | Peking Union Medical College Hospital | |
Ponatinib Plus Chemotherapy in Acute Lymphoblastic Leukemia Patients | NCT05306301 | Chemotherapy Leukemia, Acute... | Ponatinib | 18 Years - 65 Years | Gruppo Italiano Malattie EMatologiche dell'Adulto | |
Prognostic and Predictive Factors for Small Breast Tumors | NCT03390608 | Breast Cancer | Endocrine thera... Radiotherapy Herceptin Chemotherapy Type of breast ... Age at diagnosi... Screen detected... Menopausal stat... Tumor size Estrogen recept... Tumor grade HER2-status Intrinsic subgr... Nodal status | - 100 Years | Karolinska Institutet | |
Palliative Primary Tumor Resection in Minimally Symptomatic Patients With Colorectal Cancer and Synchronous Unresectable Metastases | NCT05322486 | Colorectal Neop... Intestinal Neop... Gastrointestina... Digestive Syste... Neoplasms by Si... Neoplasms Neoplasms, Seco... Neoplasm Metast... Digestive Syste... Gastrointestina... Colonic Disease Intestinal Dise... Rectal Diseases | surgery of the ... chemotherapy | 18 Years - | State Scientific Centre of Coloproctology, Russian Federation | |
Compare S-1 Plus Oxaliplatin to S-1 as Adjuvant Chemotherapy After D2 Resection in Patients With Gastric Cancer | NCT01795027 | Gastric Cancer | S-1 plus oxalip... S-1 single | 18 Years - 70 Years | Sun Yat-sen University |